Search | Médecins Sans Frontières Access Campaign

About us
About the Access Campaign

Some of our 2023 plans

Media room

Latest news

Jobs
Get Involved!
Sign up to stay updated and find out how you can get involved.

Email Address

Data protection consent

I want to receive emails from MSF and I have read and agree with the privacy policy.
Our work
COVID-19

Explainer: A bold proposal at the WTO by India and South Africa

Diabetes

Drug-resistant infections

HIV/AIDS

Hepatitis C

Hypertension

Patents and intellectual property

Pandemic prevention, preparedness and response

The Patent Oppositions Database

Research and development

Spotlight on: the Big Pharma double-dip

Transparency Matters: Clinical Trials Costs

Tropical and neglected diseases

Spotlight on: Snakebite

Tuberculosis

Vaccines

Explainer: COVID-19 vaccines - Recommendations for equitable access
Get Involved!
Sign up to stay updated and find out how you can get involved.

Email Address

Data protection consent

I want to receive emails from MSF and I have read and agree with the privacy policy.
Get involved
Campaign success stories

#NoMoreTears Johnson & Johnson Can you hear us?

A Fair Shot

Novartis 'Drop the case'

Trans-pacific Partnership (TPP)

Recent campaigns

Time for $5

No Patents in a Pandemic

Share the Tech - Save Lives
Take Action

Get Involved!
Sign up to stay updated and find out how you can get involved.

Email Address

Data protection consent

I want to receive emails from MSF and I have read and agree with the privacy policy.
Resources
Press releases

Statements

Letters

Opinion articles

Feature stories

Interviews

Blog

Newsletters

Publications

Research articles

Topic overview pages

Spotlight pages

Videos

Photo stories

Infographics

Events
Get Involved!
Sign up to stay updated and find out how you can get involved.

Email Address

Data protection consent

I want to receive emails from MSF and I have read and agree with the privacy policy.

Medicines shouldn’t be a luxury Take action

6 results found
There are 4 active filters
Clear all filters
Ebola
Zika
Research and development

6 results found

Thumbnail

Feature story

Then & Now in Access to Medicines: Changes & Challenges

Tags Hepatitis CHIV/AIDSResearch and developmentTuberculosisVaccines Ebolahepatitis CHIV/AIDSsleeping sicknesstuberculosis Access Campaign: 20 Years

Statement |

25 January 2017

MSF comments to the Department of Defense intent to grant exclusive license of patents on a Zika vaccine candidate

Tags Research and development Zika vaccines intellectual property & traderesearch and development (R&D) Sanofi

Statement |

25 January 2016

138th WHO EB - “International Health Regulations: A good framework with weak foundations”

Tags Research and development Ebola WHO Executive BoardWorld Health Organization

Technical brief |

22 January 2016

138th WHO EB - Briefing on R&D Blueprint- Agenda Item 9.1

Tags Research and development Ebola research and development (R&D) WHO Executive BoardWorld Health Organization

Statement |

16 October 2014

MSF responds to GSK remarks on Ebola vaccine

Tags Research and developmentVaccines Ebola vaccines